(Q50745207)

18 March 2018

title

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings (English)

1 reference

18 March 2018

World Health Organization

main subject

1 reference

Charles F Gilks

0 references

Siobhan Crowley

1 reference

18 March 2018

Yves Souteyrand

object named as

Yves Souteyrand

1 reference

18 March 2018

Teguest Guerma

object named as

Teguest Guerma

1 reference

18 March 2018

author name string

René Ekpini

1 reference

18 March 2018

Sandy Gove

1 reference

18 March 2018

Jos Perriens

1 reference

18 March 2018

Don Sutherland

1 reference

18 March 2018

Marco Vitoria

1 reference

18 March 2018

Kevin De Cock

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 August 2006

1 reference

18 March 2018

published in

The Lancet

1 reference

18 March 2018

volume

368

1 reference

18 March 2018

issue

9534

1 reference

18 March 2018

page(s)

505-510

1 reference

18 March 2018

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

Evaluation of microscope condition in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

Public health in the new era: improving health through collective action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969158-7

7 January 2021

10.1016/S0140-6736(06)69158-7

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018